Draper touts new bioprocessing method as ‘next big advance in CAR T-cell treatment’ – BioPharma-Reporter.com
BioPharma-Reporter.com |
Draper touts new bioprocessing method as 'next big advance in CAR T-cell treatment'
BioPharma-Reporter.com Viral vectors, the delivery vehicle of genomic materials into specific cells, can account for as much as 75% of a treatment's cost, according to the company. “Second, the device removes the expense of additional touch labor and reduces the potential … |
